Illumina | ILMN - Ebit

Aktienkurs
127.88
Täglich Wechseln
2.44 1.95%
Monatlich
1.33%
Jährlich
65.33%
Q2 Prognose
125.14




Ebit Veränderung Datum
Agilent USD 353M 90M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD -418.8M 845.4M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 11M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -37.3M 82.5M 2025-12
Repligen USD 19.97M 3.16M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Standard Biotools USD -21.92M 10.97M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 270.52M 78.4M 2025-12